Saturday , July 20 2024
Susan Wood, director of the FDA's Office of Women's Health, has submitted her resignation in protest over what appears to be another instance of the Bush Administration overruling the opinions of its own scientists.

FDA Official Resigns Over Delay In Approval of Emergency Contraception

During his Senate confirmation hearings, Food and Drug Administration Commissioner Lester Crawford pledged to Congress that if confirmed he’d see to it that the FDA would issue a decision by September 1 on whether to approve the “morning after” contraception pill Plan B. But on August 26, the FDA announced a new 60-day comment period that would delay its decision well past the stated deadline. And today, the Associated Press reports that Susan Wood, director of the FDA’s Office of Women’s Health, has submitted her resignation in protest over what appears to be another instance of the Bush Administration overruling the opinions of its own scientists.

Despite Crawford’s pledge, and despite the FDA’s finding that “the available scientific data are sufficient to support the safe use of Plan B as an OTC [over the counter] product … for women who are 17 years of age and older,” sexually active women and couples will have to continue to wait and see if they’ll ever be able to acquire the drug, which is manufactured by Barr Pharmaceuticals, over the counter. “I can no longer serve as staff when scientific and clinical evidence, fully evaluated and recommended for approval by the professional staff here, has been overruled,” Wood said in an email.

Plan B uses a high dose of the hormone levonorgestrel (which is used in lower doses in traditional birth control pills) to prevent the fertilization of an egg after intercourse has occurred.

Opponents of making Plan B available without a prescription have cited a concern that girls under seventeen would be more likely to engage in “risky behavior” (in other words, sexual intercourse) if they had access to a day-after pill, increasing their risk of catching sexually transmitted diseases. But Wood and other women’s health advocates claim the FDA’s delay is political and has more to do with the Government’s anti-choice agenda. That the availability of dangerous and deadly addictive drugs like alchohol and tobacco without a prescription seems to mean so little to these allegedly “pro-life” activists and politicians, whose concern for the well-being of fertilized eggs seems always to trump any concern they may have for humans who already exist, makes their supposed worry about STDs seem disingenuous at best.

About Jon Sobel

Jon Sobel is Publisher and Executive Editor of Blogcritics as well as lead editor of the Culture & Society section. As a writer he contributes most often to our Music section, where he covers classical music (old and new) and other genres, and to Culture, where he reviews NYC theater. Through Oren Hope Marketing and Copywriting at http://www.orenhope.com/ you can hire him to write or edit whatever marketing or journalistic materials your heart desires. Jon also writes the blog Park Odyssey at http://parkodyssey.blogspot.com/ where he is on a mission to visit every park in New York City. He has also been a part-time working musician, including as lead singer, songwriter, and bass player for Whisperado.

Check Also

Nigel Gore in 'Émilie: La Marquise du Châtelet Defends Her Life Tonight' at the Flea Theater (photo credit: Ashley Garrett)

Theater Review (NYC): ‘Émilie: La Marquise du Châtelet Defends Her Life Tonight’ by Lauren Gunderson

The NYC premiere of a play about the 18th-century female scientist is at the Flea Theater in an illuminating and finely chiseled production.